REAL-WORLD TREATMENT ADHERENCE AND OVERALL SURVIVAL IN CANCER PATIENTS RECEIVING PEMBROLIZUMAB THROUGH A PATIENT ASSISTANCE PROGRAM AT MILITARY HOSPITAL 175. YHCĐ [Internet]. 2026 Aug. 14 [cited 2026 Sept. 8];67(Số CĐ12- Bệnh viện Ung bướu Nghệ An). Available from: https://tapchiyhcd.vn/index.php/yhcd/article/view/6167